logo
The HIV Netherlands Australia Thailand research collaboration
Assessment of longitudinal changes in HIV-specific effector activity in subjects undergoing untreated primary HIV infection
Interleukin-2 therapy restores CD8 cell non-cytotoxic anti-HIV responses in primary infection subjects receiving HAART
T-cell function after interleukin-2 therapy in HIV-infected patients is correlated with serum cortisol concentrations
Levels and patterns of neutrophil cell counts over the first 8 years of life in children of HIV-1-infected mothers
Multiple mutations in human immunodeficiency virus-1 integrase confer resistance to the clinical trial drug S-1360
Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV
Survival in patients with HIV infection and viral hepatitis B or C
Long-term safety of discontinuation of secondary prophylaxis against Pneumocystis pneumonia
The impact of attending a behavioural intervention on HIV incidence in Masaka, Uganda
Cost-effectiveness of HIV postexposure prophylaxis following sexual or injection drug exposure in 96 metropolitan areas in the United States
Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections
How effective is HAART in HCV and HIV coinfection?
Prospects for an AIDS vaccine
HIV-1 Env-specific cytotoxic T-lymphocyte responses in exposed, uninfected Kenyan sex workers
IL-7 and Flt-3L plasma levels are increased during highly active antiretroviral therapy-associated IL-2 therapy
Higher efavirenz concentrations determine the response to viruses carrying non-nucleoside reverse transcriptase resistance mutations
Predictors of selection of K65R
Heterosexual transmission of multiple highly conserved viral variants in HIV-1 subtype C-infected seronegative women
Simplified one-step antibody-HLA directed expansion of HIV-specific cytotoxic T lymphocytes
Comments on the review ‘Care of patients with hepatitis C and HIV co-infection’ by Soriano et al.
Reply to Bruno et al.
Human resources in scaling up HIV/AIDS programmes
Addressing the educational void during the antiretroviral therapy rollout
Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection
Treating people with intercurrent infection in HIV prevention trials